Markets › LSE › 0I1B.L

Enovis Corporation

LSE:0I1B.LHealthcare

——At close · Market cap — · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	37.0%	46.1%	47.2%	58.2%	48.7%	51.9%	—	—
Operating margin	7.7%	−1.6%	−1.7%	−3.8%	−0.2%	0.1%	0.1%	+0.0 pts
Net margin	1.7%	4.4%	−1.0%	−1.9%	−39.2%	−52.6%	−52.6%	+0.0 pts
EBITDA margin	13.4%	6.7%	14.4%	10.0%	−22.8%	13.2%	—	—
Return on equity	1.5%	1.4%	−0.4%	−1.0%	−32.2%	−79.4%	−79.3%	+0.1 pts
Return on assets	0.7%	0.7%	−0.4%	−0.7%	−17.5%	−30.8%	−30.8%	+0.0 pts
Return on capital employed	3.6%	−0.3%	−0.7%	−1.6%	−0.1%	0.1%	—	—
Debt / equity	0.7×	0.5×	0.1×	0.2×	0.6×	1.0×	1.0×	−0.2%
Debt / assets	32.8%	25.4%	7.8%	11.9%	30.2%	37.5%	—	—
Interest coverage	2.2×	−0.8×	−1.1×	−3.3×	−0.1×	0.0×	—	—
Current ratio	1.7×	2.3×	1.4×	2.4×	2.2×	2.0×	2.0×	+0.0%
Quick ratio	1.0×	1.9×	0.7×	1.2×	1.1×	1.0×	—	—
Cash ratio	0.1×	0.7×	0.0×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.4×	0.2×	0.4×	0.4×	0.4×	0.6×	—	—
Inventory turnover	3.4×	2.2×	1.9×	1.5×	2.0×	1.9×	—	—
Receivables turnover	5.9×	5.6×	5.8×	5.9×	5.2×	5.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.